🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT05612347
Recruiting Not applicable

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

NCT05612347 · tracked via the Priya Life Science Canada tracker
Sponsor
Dartmouth-Hitchcock Medical Center
Phase
Not applicable
Started
2023-06-14
Last updated
2026-08-13

Condition(s) studied

Colorectal PolypColorectal NeoplasmsColorectal AdenomaColorectal CancerDigestive System Disease

Investigational drug(s) / intervention(s)

FITColonoscopy

FIT: Annual FIT

Colonoscopy: One time surveillance colonoscopy

Study summary

This is a multi-site comparative effectiveness randomized controlled trial (RCT) comparing annual fecal immunochemical testing (FIT) and colonoscopy for post-polypectomy surveillance among adults aged 65-82 with a history of colorectal polyps who are due for surveillance colonoscopy.

Eligibility

Sex
ALL
Min age
65 Years
Max age
82 Years
Healthy volunteers
No
Inclusion Criteria: * English or Spanish speaking * Personal history of colorectal polyps * Most recent colonoscopy with ≤2 non-advanced polyps * Currently due or coming due within 12 months for colonoscopy * Able to provide written informed consent Exclusion Criteria: * Personal history of colorectal cancer * Personal history of genetic syndrome with high risk for colorectal cancer (e.g. Lynch Syndrome, Familial Adenomatous Polyposis Syndrome (FAP), or Serrated Polyposis Syndrome) * Personal history of inflammatory bowel disease (e.g. ulcerative colitis, Crohn's disease) * Most recent colonoscopy with advanced polyp(s) or ≥3 non-advanced polyps * Patients unlikely to benefit from polyp surveillance (e.g., history of heart disease or coronary artery disease with treatment in the last 6 months, heart failure affecting function, lung disease requiring use of home oxygen, stroke within the last 4 months, dementia affecting activities of daily living (ADL) or instrumental activities of daily living (IADL), severe liver disease requiring the use of certain medications to control fluid, confusion, or bleeding, severe kidney disease requiring dialysis, or a new cancer diagnosis within the last year) * Patients unable to provide written informed consent

Primary outcome measure(s)

Trial sites (24)

FacilityCityRegionStatus
University of Alabama Birmingham Birmingham Alabama Active Not Recruiting
University of Arizona Tucson Arizona Recruiting
Jennifer Moreno Department of Veterans Affairs Medical Cneter San Diego California Recruiting
Kaiser Permanente Northern California Walnut Creek California Recruiting
University of Colorado Aurora Colorado Recruiting
MedStar Health Washington D.C. District of Columbia Recruiting
James A. Haley Veterans Hospital Tampa Florida Recruiting
Northwestern Memorial Hospital Chicago Illinois Recruiting
Richard L. Roudebush VA Medical Center Indianapolis Indiana Recruiting
University of Michigan Health Ann Arbor Michigan Recruiting
Henry Ford Detroit Michigan Recruiting
Washington University School of Medicine St Louis Missouri Recruiting
Dartmouth Health Lebanon New Hampshire Recruiting
New York Harbor Health Care System - Dept of Veterans Affairs New York New York Recruiting
Wake Forest University Health Sciences Charlotte North Carolina Recruiting
Kaiser Permanente Northwest Portand Oregon Active Not Recruiting
Oregon Health & Science University (Knight Cancer Institute) Portland Oregon Recruiting
University of Utah Salt Lake City Utah Recruiting
Intermountain Health Sandy City Utah Recruiting
University of Virginia Health Charlottesville Virginia Recruiting
University of Calgary Calgary Alberta Recruiting
University of British Columbia Vancouver British Columbia Recruiting
University of Manitoba Winnipeg Manitoba Recruiting
London Health Sciences Centre Research Institute London Ontario Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05612347 on ClinicalTrials.gov ↗ ← All trials in Canada